Canlyniadau Chwilio - Nurmohamed, Michael

Atherogenic lipid profiles and its management in patients with rheumatoid arthritis gan Nurmohamed, Michael T

Cael y testun llawn Cael y testun llawn

The increased cardiovascular risk in rheumatoid arthritis: when does it start? gan Nurmohamed, Michael T

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Are biologics more effective than classical disease-modifying antirheumatic drugs? gan Nurmohamed, Michael T, Dijkmans, Ben AC

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step? gan Peters, Mike JL, Nurmohamed, Michael T

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Biologics, cardiovascular effects and cancer gan Damjanov, Nemanja, Nurmohamed, Michael T, Szekanecz, Zoltán

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Editorial: Comorbidity Burden in Rheumatic Diseases gan Nikiphorou, Elena, Nurmohamed, Michael T., Szekanecz, Zoltan

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice gan Agca, Rabia, Smulders, Yvo, Nurmohamed, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022 gan Dijkshoorn, Bas, Raadsen, Reinder, Nurmohamed, Michael T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Management and evaluation of extra-articular manifestations in spondyloarthritis gan van der Horst-Bruinsma, Irene E., Nurmohamed, Michael T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Unresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence-Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis gan Solomon, Daniel H, Peters, Mike J L, Nurmohamed, Michael T, Dixon, Will

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Multicentric reticulohistiocytosis: a case report gan Farokhi, Azadèh, van Vugt, Richard M., Hoekzema, Rick, Nurmohamed, Michael T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical improvement of cardiac function in a patient with systemic lupus erythematosus and heart failure with preserved ejection fraction treated with belimumab gan Baniaamam, Milad, Voskuyl, Alexandre E, Nurmohamed, Michael T, Handoko, M Louis

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Coagulation in gout: is there a link with disease activity? gan Vedder, Daisy, Gerritsen, Martijn, Meijers, Joost C. M., Nurmohamed, Michael T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction to: Coagulation in gout: is there a link with disease activity? gan Vedder, Daisy, Gerritsen, Martijn, Meijers, Joost C. M., Nurmohamed, Michael T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome gan Raterman, Hennie G, Voskuyl, Alexandre E, Dijkmans, Ben AC, Nurmohamed, Michael T

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study gan van Sijl, Alper M., Boers, Maarten, Voskuyl, Alexandre E., Nurmohamed, Michael T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment gan Choy, Ernest, Ganeshalingam, Kandeepan, Semb, Anne Grete, Szekanecz, Zoltán, Nurmohamed, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion gan van den Oever, Inge A.M., van Sijl, Alper M., Nurmohamed, Michael T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A neutrophil signature is strongly associated with increased cardiovascular risk in gout gan Vedder, Daisy, Gerritsen, Martijn, Nurmohamed, Michael T, van Vollenhoven, Ronald F, Lood, Christian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review gan Nurmohamed, Michael, Choy, Ernest, Lula, Sadiq, Kola, Blerina, DeMasi, Ryan, Accossato, Paola

Cael y testun llawn Cael y testun llawn Cael y testun llawn